NR3C1 and major depressive disorder: On the other hand, Tyrka et al. [27] reported significantly lower NR3C1 methylation across the promoter region and at six other CpG sites in people with a history of childhood abuse and/or major depressive disorder, bipolar disorder, or generalized anxiety disorder.